Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-029866

Chief Commercial Officer bought 5,000 shares at $5.02 ($25,075)

From the SEC's structured data for this filing

Trades in this filing

Habig Scott Michael · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-09 Purchase : show line 1 in the form +5,000 $5.02 $25,075 5,000 D
Open-market purchases · 5,000 sh · avg $5.02 · $25,075
Loading xslF345X03/wf-form4_166846148591533.xml…